On Tuesday, Nemaura Medical Inc. (NASDAQ: NMRD) shares price traded between $2.08 and $2.29 during the last trading session below with -0.92% at $2.15. The shares recorded a trading volume 51,925 million shares as compared to its average volume of 31,111 shares. The company has 205M shares outstanding and market value of 440.75M. Over the one year trading period, the stock has a peak price of $6.80 and its down is recorded at $2.08. The short ratio in the stock is 0.73 and the short float is around of 0.06%.
Nemaura Medical Inc. (NASDAQ: NMRD) stated financial results for the first quarter ended June 30, 2018.
Dr Faz Chowdhury, CEO of Nemaura Medical commented “we have maintained our well capitalised financial position whilst incurring important additional costs from commencing FDA clinical trials and scaling up our systems in readiness for anticipated UK commercial launch of sugarBEAT® later this year. This financial strength should allow us to start to generate sales revenues without requiring additional capital.”
First Quarter 2018 results:
Research and development expenses increased to $429,539 over the quarter ending June 2018, a raise from $149,198 for the same quarter in 2017.
General and Administrative expenses increased to $342,424 for the quarter ending June 2018, contrast to $268,122 for the same quarter in 2017.
The Company’s comprehensive loss was $997,763 for the quarter ending June 2018, a raise of $792,731 for the same quarter in 2017.
At June 30, 2018, the Company’s combined cash and bank fixed deposits was $4,941,042.
The average true range of Nemaura Medical Inc.’s (NMRD) is recorded at 0.22 and the relative strength index of the stock stands 43.25. The stock price is going above to its 52 week low with 4.88% and lagging behind from its 52 week high with -68.38%. A look on the firm performance, its monthly performance is -6.93% and a quarterly performance of -23.21%. The stock price is trading downbeat from its 200 days moving average with -46.01% and down from 50 days moving average with -11.77%.